Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2012

01-08-2012 | Perspectives

A New Taxonomy for Stakeholder Engagement in Patient-Centered Outcomes Research

Authors: Thomas W. Concannon, PhD, Paul Meissner, MSPH, Jo Anne Grunbaum, EdD, Newell McElwee, Pharm.D, MSPH, Jeanne-Marie Guise, MD, MPH, John Santa, MD, MPH, Patrick H. Conway, MD, MSc., Denise Daudelin, RN, MPH, Elaine H. Morrato, DrPH, MPH, Laurel K. Leslie, MD, MPH

Published in: Journal of General Internal Medicine | Issue 8/2012

Login to get access

Abstract

Despite widespread agreement that stakeholder engagement is needed in patient-centered outcomes research (PCOR), no taxonomy exists to guide researchers and policy makers on how to address this need. We followed an iterative process, including several stages of stakeholder review, to address three questions: (1) Who are the stakeholders in PCOR? (2) What roles and responsibilities can stakeholders have in PCOR? (3) How can researchers start engaging stakeholders? We introduce a flexible taxonomy called the 7Ps of Stakeholder Engagement and Six Stages of Research for identifying stakeholders and developing engagement strategies across the full spectrum of research activities. The path toward engagement will not be uniform across every research program, but this taxonomy offers a common starting point and a flexible approach.
Literature
1.
Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med. 2010;7:e1000326.PubMedCrossRef
2.
3.
4.
Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365:176–86.PubMedCrossRef
5.
Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. Treating individuals 3: from subgroups to individuals: General principles and the example of carotid endarterectomy. Lancet. 2005;365:256–65.PubMed
6.
Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209–12.PubMedCrossRef
7.
Killien M, Bigby JA, Champion V, et al. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health. J Womens Health Gend Based Med. 2000;9:1061–70.PubMedCrossRef
8.
Yancey AK, Ortega AN, Kumanyika SK. Effective recruitment and retention of minority participants. Annu Rev Public Health. 2006;27:1–28.PubMedCrossRef
9.
Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004;364:803–811.PubMedCrossRef
10.
Institute of Medicine. Initial Priorities for Comparative Effectiveness Research. Washington: National Academies Press; 2009.
11.
12.
13.
McClellan M, Benner J, Garber AM, Meltzer DO, Tunis SR, Pearson S. Comparative Effectiveness Research: Will It Bend the Health Care Cost Curve and Improve Quality? Washington: The Brookings Institute; 2009.
14.
Roehr B. More stakeholder engagement is needed to improve quality of research, say US experts. Br Med J. 2010;341:c4193.CrossRef
15.
Conway PH, Clancy C. Charting a path from comparative effectiveness funding to improved patient-centered health care. JAMA. 2010;303:985–6.PubMedCrossRef
16.
Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. Washington: National Academies Press; 2009.
17.
Harvard Business School Press. The Essentials of Negotiation. Boston: Harvard Business School Publishing; 2005.
18.
Malhotra D, Bazerman MH. Negotiation Genius. New York: Bantam Books; 2008.
19.
Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington: The National Academies Press; 2011.
20.
Selker HP, Leslie LK, Wasser JS, Plaut AG, Wilson IB, Griffith JL, Tufts CTSI. Tufts CTSI. Clin Transl Sci. 2010;3:56–8.PubMedCrossRef
21.
Minkler ME, Wallerstein NE. Community Based Participatory Research for Health. San Francisco: Jossey-Bass; 2003.
22.
CTSA Community Engagement Key Function Committee. Principles of Community Engagement. 2nd ed. Washington: U.S. Department of Health and Human Services; 2011.
23.
Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173–202.PubMedCrossRef
24.
O’Haire C, McPheeters M, Nakamoto EK, et al. Methods for Engaging Stakeholders To Identify and Prioritize Future Research Needs. Rockville: Agency for Healthcare Research and Quality; 2011. AHRQ Publication No. 11-EHC044-EF.
25.
Hoffman A, Montgomery R, Aubry W, Tunis SR. How best to engage patients, doctors, and other stakeholders in designing comparative effectiveness studies. Health Aff. 2010;29:1834–41.CrossRef
26.
Medicare prescription drug, improvement, and modernization act of 2003, H.R.1, 108th Congress.
27.
Patient-Centered Outcomes Research Institute. Draft National priorities for research and research agenda, version 1. Washington; 2012.
28.
Luce BR, Kramer JM, Goodman SN, et al. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009;151:206–9.PubMed
29.
Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–32.PubMedCrossRef
30.
Ware JH, Hamel MB. Pragmatic trials: guides to better patient care? N Eng J Med. 2011;364:1685–7.CrossRef
31.
Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303:2359–67.PubMedCrossRef
32.
Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD. JAMA. 2010;303:2409–10.PubMedCrossRef
33.
Institute of Medicine. Finding What Works in Health Care: standards for Systematic Reviews. Washington: National Academies Press; 2011.
34.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2008.
35.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.PubMedCrossRef
36.
Facey K, Boivin A, Gracia J, et al. Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation. Int J Tech Assess Health Care. 2010;26:334–40.CrossRef
37.
Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA. 2008;300:436–8.PubMedCrossRef
38.
39.
Benner JS, Morrison MR, Karnes EK, Kocot SL, McClellan M. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps. Health Aff. 2010;29:1768–76.CrossRef
40.
Lauer MS, Collins FS. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA. 2010;303:2182–3.PubMedCrossRef
41.
Selker HP, Strom BL, Ford DE, et al. White paper on CTSA consortium role in facilitating comparative effectiveness research. Clin Transl Sci. 2010;3:29–37.PubMedCrossRef
42.
43.
Wells K, Miranda J, Bruce ML, Alegria M, Wallerstein N. Bridging community intervention and mental health services research. Am J Psychiatry. 2004;161:955–63.PubMedCrossRef
44.
Leung MW, Yen IH, Minkler M. Community based participatory research: a promising approach for increasing epidemiology's relevance in the 21st century. Int J Epid. 2004;33:499–506.CrossRef
45.
Seifer S. Building and sustaining community-institutional partnerships for prevention research: findings from a national collaborative. J Urban Health. 2006;83:989–1003.PubMedCrossRef
46.
47.
Rosengren K, Trinity M. Roundtable on expanding capacity for comparative effectiveness research in the United States. Heal Serv Res. 2009;44:327–42.CrossRef
Metadata
Title
A New Taxonomy for Stakeholder Engagement in Patient-Centered Outcomes Research
Authors
Thomas W. Concannon, PhD
Paul Meissner, MSPH
Jo Anne Grunbaum, EdD
Newell McElwee, Pharm.D, MSPH
Jeanne-Marie Guise, MD, MPH
John Santa, MD, MPH
Patrick H. Conway, MD, MSc.
Denise Daudelin, RN, MPH
Elaine H. Morrato, DrPH, MPH
Laurel K. Leslie, MD, MPH
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 8/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2037-1

Other articles of this Issue 8/2012

Journal of General Internal Medicine 8/2012 Go to the issue

Reviews

Cervical Cancer Screening, Diagnosis and Treatment Interventions for Racial and Ethnic Minorities: A Systematic Review

Reviews

Interventions to Improve Care Related to Colorectal Cancer Among Racial and Ethnic Minorities: A Systematic Review

Original Research

Relationship of Electronic Medical Knowledge Resource Use and Practice Characteristics with Internal Medicine Maintenance of Certification Examination Scores

Original Research

Electronic Tools to Assist with Identification and Counseling for Overweight Patients: a Randomized Controlled Trial

Reviews

Changing Clinical Practice Through Patient Specific Reminders Available at the Time of the Clinical Encounter: Systematic Review and Meta-Analysis

Clinical Practice: Clinical Images

The Art in Dermatitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits